from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3480c/-

LFCtreatmentdescriptionclass of inhibitor

-0.682

Amikacinug/mL Amikacintranslation

-0.396

Cap5-10ug/mL Capreomycintranslation

-0.550

Rox10-50 ug/mL Roxithromycintranslation

-0.432

SM2-5 ug/mL Streptomycintranslation

1.087

Tet5-10 ug/mL Tetracyclinetranslation

1.340

Rif0.2-5ug/mL Rifampicintranscription

0.258

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.582

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.075

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.853

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.355

Clofazimine10-13 ug/mL Clofaziminerespiration

0.440

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.543

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.012

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.244

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.095

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.337

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.961

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.767

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.897

KCN5-20 ug/mL Potassium cyaniderespiration

-0.831

NaN30.2-2 mM Sodium aziderespiration

-0.849

Nigericin50 uM Nigericinrespiration

-0.148

TRC10-150 ug/mL Triclosanrespiration

-0.479

TRZ10-25 ug/mL Thioridazinerespiration

-1.452

Valinomycin0.5-10 uM Valinomycinrespiration

-0.913

ZnSO42 mM ZnSO4respiration

-1.210

menadione6-10 ug/mL Menadionerespiration

-0.129

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.120

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.306

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.092

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.043

NRP_1Non-replicating persistence stage 1dosRassociated

-0.179

Amp0.2mg/mL AmpicillincellWall

-0.067

Cephalexin20-100 ug/mL CephalexincellWall

-0.124

Cerulenin0.32-5 ug/mL CerulenincellWall

0.085

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.233

EMB10-20 ug/mL EthambutolcellWall

-0.231

Eta12-40 ug/mL EthionamidecellWall

-0.346

INH0.2-0.4 ug/mL IsoniazidcellWall

0.186

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.885

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.828

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.497

BZA0.12 mg/mL BenzamidearomaticAmides

1.184

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.598

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.900

H2O24 mM hydrogen peroxideDNAdamaging

-0.064

Levo10 ug/mL LevofloxacinDNAdamaging

0.006

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.340

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.034

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.541

UVUV-irradiationDNAdamaging

-1.549

ARP41-4 ug/mL Antitubercular compound ARP4?

0.161

Antimycin12.5-50 ug/mL Antimycin A?

-0.135

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.037

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.144

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.256

PA8240.2-2 ug/mL PA-824?

-0.310

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.060

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.406

Verapamil50 uM Verapamil?

-0.747

mercaptoethanol2 mM 2-Mercaptoethanol?

0.174

methoxatin10-20 ug/mL Methoxatin?